Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance
about
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulationWhat a Dinner Party! Mechanisms and Functions of Interkingdom Signaling in Host-Pathogen Associations.The Challenge and Potential of Metagenomics in the ClinicAntibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic ClassInteractions between the microbiota and pathogenic bacteria in the gutRoles of the intestinal microbiota in pathogen protection.Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.Microbiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection.The microbiota and immune response during Clostridium difficile infection.Introduction to the human gut microbiotaThe gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape.Selective enrichment of commensal gut bacteria protects against Citrobacter rodentium-induced colitis.Analysis of Bacterial Communities during Clostridium difficile Infection in the MouseFrenemies: Signaling and Nutritional Integration in Pathogen-Microbiota-Host InteractionsRegulation of virulence: the rise and fall of gastrointestinal pathogens.Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria.From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease.Stress as a Normal Cue in the Symbiotic Environment.Role of Autophagy in the Maintenance of Intestinal Homeostasis.Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Clostridium difficile colitis: pathogenesis and host defenceBacArena: Individual-based metabolic modeling of heterogeneous microbes in complex communities.Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic VariationBacterial Metabolism Shapes the Host-Pathogen InterfaceInsights into Butyrate Production in a Controlled Fermentation System via Gene Predictions.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.When pathogenic bacteria meet the intestinal microbiota.Microbiome therapeutics - Advances and challenges.The Traveling Microbiome.Formation of propionate and butyrate by the human colonic microbiota.The emerging metabolic view of Clostridium difficile pathogenesis.Metabolic defence against oxidative stress: the road less travelled so far.Covalent attachment and Pro-Pro endopeptidase (PPEP-1)-mediated release of Clostridium difficile cell surface proteins involved in adhesion.The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.Clostridium difficile Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes.Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection.Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria.Effects of monobutyrin and tributyrin on liver lipid profile, caecal microbiota composition and SCFA in high-fat diet-fed rats.
P2860
Q26748672-2998C429-6572-4014-B45F-83BB91EDB303Q26765110-7E65E67A-9C58-425B-B378-CD0FC9299E44Q26766414-B86C8E4E-D36F-4D28-B974-5CF017897049Q27335185-D06AB87E-D530-4646-9ECC-99E7FA86997DQ28080209-7923FF75-8293-44C3-9D56-6588A8232DE9Q30235535-C6A99C44-4DFF-4E8A-9A37-23E874CED072Q30276498-968D1604-71FC-4CCF-A79A-61D88A5D78C6Q30276689-B177AB42-772B-4255-86FC-2B83E2424CCBQ30276756-B8DF65F3-E34B-49EC-84E8-DBA363B53DF1Q33693158-CBA75460-3BA3-4048-896D-558793818AF1Q34722114-D899406E-821A-4B4B-AA2E-3B373740AAD9Q35661681-F65AD7BD-7AD0-45CE-8FEA-42B9496A147AQ35760741-419C055C-6914-4C2C-B0B2-CC03BD71CDDBQ35768800-BB6CC735-F8FE-425F-B196-5173533089D3Q35836653-D9D35B32-CB72-4284-AD30-08224F365706Q35855014-58C9F1CC-A6BA-4FFD-84F6-F019D1524FA5Q35861517-9A7C025B-F65E-4219-A90F-E3B24E17C0C9Q35966710-63D39730-5502-4A4B-9E98-DF52EB45911DQ35998480-CE791FC3-53F2-4DB1-9B75-E61D9A9B9A35Q36018079-92DA6F16-3557-4EC1-A602-4695AC644270Q36116428-26406F1B-799F-4383-AC6C-1044A8F818A7Q36377654-6FF71731-C2A4-4BB6-A46B-E845BF5361CFQ36889936-D3C8FB65-93BE-4721-8ACF-4928CBC2B5C5Q36943702-BC953FE2-B092-4319-BC1B-DE669A9BBDA5Q37041802-541F3FD0-6BA5-42F2-8BA4-241188B5E0C7Q38650196-72D3296E-1ABD-43ED-BD67-10896F522264Q38794312-C0D8B246-CC51-4915-8324-8B2556FB732BQ38817334-C4BDAB71-1FF1-4F83-8E60-29926528DEE6Q38829360-CBB15C8F-B259-4B6A-AFE3-E7FFB9522598Q38905594-2D3CBD17-A9C4-4AB9-8CE9-32E4D04EDC47Q39032599-CF609126-E914-4BCD-B77A-ADC86E232E5AQ39044660-320A10C5-D3D1-4EED-AD9A-59264E89E41AQ39369775-0C3C1ECD-3006-4EE0-BCF8-11403542F516Q39388064-1FA0FAAA-579E-428C-B2CB-B8829647CB81Q40063718-0079C408-7259-4C4B-8EDF-1634CE76A7CCQ40073307-AF077A61-8A12-4C60-8456-1F81A4B029F9Q40111848-243230AE-7221-4C1D-BBA9-7276942E0BE7Q40592428-9E449197-7598-4380-A158-6A2AFF4A44E8Q41996396-A18204EA-E199-42F7-9123-28F5731C8032Q44088617-6AA632A4-310E-48A1-B2FF-A8229D6ACF66
P2860
Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gut microbiota-produced succin ...... atment or motility disturbance
@en
type
label
Gut microbiota-produced succin ...... atment or motility disturbance
@en
prefLabel
Gut microbiota-produced succin ...... atment or motility disturbance
@en
P2093
P2860
P1433
P1476
Gut microbiota-produced succin ...... atment or motility disturbance
@en
P2093
Andrew J Hryckowian
Donna M Bouley
Jessica A Ferreyra
Justin L Sonnenburg
Katherine J Wu
P2860
P304
P356
10.1016/J.CHOM.2014.11.003
P577
2014-12-01T00:00:00Z